cGxP.wire https://validator.w3.org/feed/docs/rss2.html Evotec Expands AI Drug Discovery with Odyssey Partnership Asimov Completes Biosimilar Antibody Cell Line Campaign with Kyungdong Nicox Files NCX 470 NDA in China Through Ocumension Kiora Pharmaceuticals Advances Key Clinical Programs Innate Pharma to Advance Lacutamab Toward Phase 3 with Sobi Scholar Rock Advances Apitegromab FDA Review with Second Fill-Finish Facility Caris Life Sciences Advances AI for Breast Cancer Care Innovent and Daiichi Sankyo Partner on VANFLYTA in China Entera Bio Advances EB613 Toward Phase 3 Development Following FDA Alignment aTyr Pharma Prioritizes Efzofitimod as FDA Phase 3 Feedback Approaches Co-Diagnostics Submits FDA 510(k) for PCR Respiratory Test RiboX Advances In Vivo CAR-T With RXIM002 FDA Clearance Amylyx Pharmaceuticals Advances Avexitide Toward Phase 3 Data AbCellera to Announce ABCL635 Phase 2 Results Biogen Completes RayThera Acquisition to Expand Immunology Praxis Precision Medicines Advances Key Regulatory Programs Blacksmith Medicines Advances Novel Antibiotic Discovery Northwest Biotherapeutics Partners with SPIMACO to Advance DCVax-L in Saudi Arabia FDA Approves Tudriqev for Advanced Refractory Melanoma Compass Pathways Partners with VA to Evaluate COMP360 for Treatment-Resistant Depression Pulse Health Launches Pulse Media for Precision HCP Outreach Elanco Expands Screwworm Protection With CLiK Extra EUA X4 Pharmaceuticals Reports Q2 2026 Results and Advances Mavorixafor Development INmune Bio Reports Q2 2026 Results and Pipeline Progress Caris Expands Precision Oncology Research With UNM Alliance Definium Therapeutics Advances DT120 ODT After Positive Phase 3 Results Neurocrine Advances Obesity Pipeline With NBIP-‘1968 Trial Astellas Advances Menopause Drug Toward Japan Approval bioAffinity Technologies Reports CyPath Lung Growth Tarsus Pharmaceuticals Expands Eye Care with Alkeus Deal Philips Expands Patient Monitoring Ecosystem with Partnerships Regeneron Expands Libtayo Approval for High-Risk CSCC Alebund Pharmaceuticals Gains China NMPA NDA Acceptance BioInvent Receives FDA Fast Track Designation for BI-1808 IceCure Medical Expands ChoICE Study for Breast Cancer Faeth Therapeutics to Present PIKTOR PK/PD Data NRx Pharmaceuticals Clears FDA ANDA Review Aclaris Therapeutics Receives FDA Fast Track for Modzatinib Ractigen Advances Phase II Trial of RAG-17 for SOD1-ALS CancerVax Activates Human Killer T-Cells Against Cancer Reckitt Secures FDA Approval for New Mucinex 12HR Therapy GRAIL Advances Galleri FDA Review for Cancer Detection Bavarian Nordic Secures EU Approval for IMVANEX in Children Replimune Wins FDA Approval for TUDRIQEV in Melanoma MiNK Therapeutics to Present AgenT-797 Clinical Update Vivani Medical Completes Phase 1 SLIM-1 Dosing of NPM-139 Implant Propanc Biopharma Reports Strong Preclinical PRP Results Annexon Reports Rapid GBS Responses with Tanruprubart in FORWARD Study Vistagen Reports Positive Phase 2 Fasedienol Repeat-Dose Data Ascendis Pharma Shows Positive Long-Term COACH Results